3.  Pharmaceutical benefit managers (PBM) We manage prescription benefits for tens of millions of Americans on behalf of thousands of clients, including health plans and plan sponsors. Employers, unions and government organizations throughout the nation rely on our services. Our team of more than 30,000 employees expresses passion, expresses care and expresses enthusiasm for our mission. We are committed to our members achieving better clinical outcomes and dedicated to delivering better financial outcomes for plan sponsors. ~ George Paz, Chairman & CEO https://www.express-scripts.com/aboutus/index.shtml  Specialty Prescription Management

4.  Benefit Design Consultation.  Patient Care Contact Centers  Formulary development  Information Reporting and Analysis Programs  Rebate Programs  Electronic Claims Processing System  Consumer Health and Drug Issues

5.  United Health Group  CVS Caremark  Omnicare  Rite Aid Express Scripts’ wide moat gives it a great advantage over their competitors. This can be attributed to three main “pillars:” 1) Sticky client base 2) Strong foothold within pharmaceutical markets. 3) The company’s scale advantage.

6. ESRX Revenue (in millions $)FY 2014FY 2013FY 2012FY 2011 IV QuarterDec.26,312.6025,781.4027,410.7012,101.40 III QuarterSep.25,778.5025,915.6026,999.4011,571.00 II QuarterJune25,111.0026,425.0027,692.5011,361.40 I QuarterMarch23,685.0026,063.0012,132.6011,094.50 FY 100,887.10104,098.8093,858.1046,128.30 http://csimarket.com/stocks/single_growth_rates.php?code=ESRX&rev

7.  George Paz: Chairman & Chief Executive Officer ◦ Salary: $1.07mil with a bonus of $2.02mil. He also receives stock gains of $34.99mil Keith Ebling: Executive Vice President & General Counsel: Salary: $660,385 and $662,540 was received as a bonus, & $900,000 was received in stock options Jim Havel: Executive Vice President & Interim Chief Financial Officer. Salary: $725,000 and a signing bonus of $110,000, Christine Houston Senior Vice President - Operations Steve Miller, MD Senior Vice President & Chief Medical Officer Tim Wentworth: President Salary: $815,303, Bonus:1,264,863,

8. Profitability Ratio 2012 2014_________________________ Profit Margin:.014.019 (+) Return on assets:.023.037 (+) Return on Equity:.056.100 (+) Asset Utilization: Receivables turnover: 16.08 15.83 (-) Total Asset turnover: 1.74 1.88 (+) NWC turnover: -.025 -.064 (-) Liquidity Ratio Current ratio:.82.62 (-) Quick ratio:.68.50 (-) NWC to total assets: -.04 -.61 (-) Leverage Ratio: Total Debt ratio:.96.63 (+) Equity multiplier: 2.49 2.68 (-) D/E ratio:.64.55 (+)

9. Value 1 Weight Required rate of return 2 Calculation Equity (fair value)63,878,599 0.82 16.07% Long-term debt, including current maturities (fair value) 14,200,200 0.182.38% = 3.78% × (1 – 37.08%) USD $ in thousands Equity (fair value) = No. shares of common stock outstanding × Current share price = 729,291,000 × $87.59 = $63,878,598,690.00 Long-term debt, including current maturities (fair value). Required rate of return on equity is estimated by using CAPM. Required rate of return on debt. Required rate of return on debt is after tax. Estimated (average) effective income tax rate = (33.60% + 36.40% + 38.00% + 37.00% + 36.90%) ÷ 5 = 37.08% WACC = 13.58% https://www.stock-analysis-on.net/NASDAQ/Company/Express-Scripts-Holding-Co/DCF/Present-Value-of-FCFF

10.  2009- Express Scripts Completes Acquisition of WellPoint’s NextRx Subsidiaries  Hepatitis Cure Value Program  The transaction includes a 10-year agreement under which Express Scripts, one of the largest pharmacy benefits management companies in North America, will provide pharmacy benefits management services, including home delivery and specialty pharmacy services, to members of the affiliated health plans of WellPoint, one of the nation’s largest health benefits companies. Express Scripts acquired the NextRx subsidiaries for $4.675 billion, which includes consideration for the value of a future tax benefit for Express Scripts based on the structure of the transaction.

11.  Merger with Medco Health Solutions "Our merger is exactly what the country needs now, It represents the next chapter of our mission to lower costs, drive out waste in healthcare and improve patient health. We remain focused on formulary management, channel management and closing gaps in care, which will allow us to further improve the health of people with chronic and complex medical conditions. ~ George Paz, CEO

12. TickerCompany Market Cap (Millions) 5-Year Sales Growth Debt/EquityProfit Margin ESRX Express Scripts Holding Company $60,830.0036.50%0.731.90%

13.  Initial public offering in 1992  Express Scripts Holding Company (ESRX)  -NasdaqGS 87.59 1.24(1.40%)  Beta:.64  CVS Health Corporation (CVS)  -NYSE  104.19 2.19(2.06%)  Beta:1.17  Omnicare Inc. (OCR)  -NYSE  94.55 0.06(0.06%)  Beta:.47

14. DateResearch FirmActionCurrentPT 12/04/14Deutsche BankMaintainsHold88.0 1/08/15JP MorganMaintainsOverweight100.0 1/08/15BarclaysMaintainsOverweight102.0 1/28/15FBR CapitalDowngrades Market Perform 2/26/15Deutsche BankMaintainsHold96.0 4/10/15BMO CapitalMaintains Market Perform 89.0 5/20/15Baird Initiates Coverage on Neutral94.0 6/01/15 Raymond James Downgrades Market Perform 6/15/15Deutsche BankMaintainsHold95.0 6/17/15Oppenheimer Initiates Coverage on Perform http://www.benzinga.com/stock/esrx/ratings

15. 06/09/20151,644 Disposition at $87.14 per share. 143,259 06/01/201546,069 Disposition at $86.15 per share. 3,968,845 06/01/20154,799 Derivative/Non- derivative trans. at $77.15 per share. 370,242 06/01/20153,557 Derivative/Non- derivative trans. at $53.05 per share. 188,698 06/01/201516,356 Derivative/Non- derivative trans. at $53.05 per share. 867,685 06/01/20159,078 Derivative/Non- derivative trans. at $58.17 per share. 528,06 Transactions Date Shares Transaction Value

16. “ We are proud to provide world-class service and specialized pharmacy care to our men and women in uniform and military retirees, along with their dependents. ”

17.  Shareholder value is the sum of all strategic decisions that affect the firms ability to efficiently increase the amount of free cash flow over time.  was downgraded by ZACKS from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday,

20.  http://www.benzinga.com/stock/esrx/ratings http://www.benzinga.com/stock/esrx/ratings  http://csimarket.com/stocks/single_growth_rates.php?code= ESRX&rev http://csimarket.com/stocks/single_growth_rates.php?code= ESRX&rev  https://www.express-scripts.com/aboutus/index.shtml https://www.express-scripts.com/aboutus/index.shtml  https://www.express- scripts.com/pressroom/informationresources/corporateoverv iew/corporateOverview.pdf https://www.express- scripts.com/pressroom/informationresources/corporateoverv iew/corporateOverview.pdf  http://fortune.com/fortune500/express-scripts-holding-22/ http://fortune.com/fortune500/express-scripts-holding-22/  http://ir.antheminc.com/phoenix.zhtml?c=130104&p=irol- newsArticle&ID=1360094 http://ir.antheminc.com/phoenix.zhtml?c=130104&p=irol- newsArticle&ID=1360094

21.  https://www.stock-analysis- on.net/NASDAQ/Company/Express-Scripts-Holding- Co/DCF/Present-Value-of-FCFF https://www.stock-analysis- on.net/NASDAQ/Company/Express-Scripts-Holding- Co/DCF/Present-Value-of-FCFF  http://www.forbes.com/lists/2012/12/ceo-compensation- 12_George-Paz_23R1.html http://www.forbes.com/lists/2012/12/ceo-compensation- 12_George-Paz_23R1.html  http://www.reuters.com/finance/stocks/companyOfficers?symbo l=ESRX.O http://www.reuters.com/finance/stocks/companyOfficers?symbo l=ESRX.O  http://www.tricare.mil/overseas-pharmacy?p=1 http://www.tricare.mil/overseas-pharmacy?p=1  http://www.wsj.com/articles/SB1000142405311190355490457 6460322664055328 http://www.wsj.com/articles/SB1000142405311190355490457 6460322664055328  http://blogs.wsj.com/pharmalot/2014/12/22/the-hepatitis-c- price-wars-begin-what-the-express-scripts-move-means / http://blogs.wsj.com/pharmalot/2014/12/22/the-hepatitis-c- price-wars-begin-what-the-express-scripts-move-means /  http://www.wikinvest.com/stock/Express_Scripts_%28E SRX%29 http://www.wikinvest.com/stock/Express_Scripts_%28E SRX%29